Hoth Therapeutics, AMD, Agenus, Vale, Airbnb, Stem: Biotech News, Bullish Views
- June 06th, 2023
- 229 views
Hoth Therapeutics, Inc. (Nasdaq: HOTH) shared promising news regarding HT-ALZ, their therapeutic under development for Alzheimer's disease.
Positive preclinical results surpassed their previous study, with the higher dose showing the most beneficial effects in a spatial memory test conducted at Washington University in St. Louis.
Alzheimer's, the leading cause of dementia, affects memory and cognitive abilities, significantly impacting daily life.
Following this announcement, $HOTH closed at $3.35, reflecting a significant increase of $1.47 (+78.19%).
Advanced Micro Devices, Inc. (Nasdaq: AMD), a prominent semiconductor company known for its innovative products, had its price target raised from $110 to $150 by Piper Sandler.
With $AMD closing at $124.23 on Tuesday, this adjusted price target suggests a potential upside of $25.77 (20.74%) based on Piper Sandler's view.
Agenus Inc. (Nasdaq: AGEN), a biotechnology company dedicated to developing breakthrough immunotherapies, was initiated with an Outperform rating by Robert W. Baird, along with a price target of $8.
Despite $AGEN closing at $1.85 on Tuesday, Robert W. Baird's positive outlook implies a potential upside of $6.15 (332.43%).
Vale S.A. (NYSE: VALE), one of the world's largest mining companies, experienced an upgrade from Sector Perform to Outperform by RBC Capital Markets, accompanied by a price target increase from $13 to $15.
Given $VALE closing price of $13.73 on Tuesday, this adjustment suggests a potential upside of $1.27 (9.25%), according to RBC Capital Markets' view.
Airbnb, Inc. (Nasdaq: ABNB), a leading online vacation rental marketplace, was initiated with a Neutral rating by Wedbush, with a price target set at $130.
Despite $ABNB closing at $117.30 on Tuesday, this price target implies a potential upside of $12.70 (10.82%) based on Wedbush's analysis
Stem, Inc. (NYSE: STEM), an innovative energy storage solutions provider, caught the attention of Janney, who initiated coverage with a Buy rating and set a price target of $12.
Although $STEM closed at $5.80 on Tuesday, Janney's positive outlook indicates a potential upside of $6.20 (106.90%).
These potential upsides are based on the assessments and views of the respective brokerage firms, investment firms, or analysts, highlighting the market's expectations and sentiment towards each company's future performance.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login